Meet
Alisa Vidulich

Alisa Vidulich supports clients in a variety of healthcare sectors and with key stakeholders on federal and state policy issues, including legislative and regulatory processes.

Alisa contributes to the firm’s preventive services initiatives and has expertise in HIV/AIDS, opioids and substance abuse, emerging and infectious diseases, mental health, and broader public health topics.

Alisa has experience working in health policy, public-private partnerships, and strategic engagement with the US Centers for Disease Control and Prevention in the Division of Global HIV & TB. Previously, she engaged in local and state government affairs and advocacy in GA, OH, and WV, and notably, she served as engrossing clerk and as senior legislative aide to the majority whip in the Ohio House of Representatives. Alisa has also worked at a health technology company seeking to create a patient identity solution for hospitals and health systems to curb opioid and prescription drug misuse.

Alisa earned her MPH in policy and management from Emory University Rollins School of Public Health and has a BA in French and international studies with a concentration in global economic development from the University of Dayton.

Authored Content


Avalere analysis of Medicare fee-for-service (FFS) hospital stay claims with associated COVID-19 diagnoses finds that total US healthcare system costs for hospitalizations due to COVID-19 could range from $9.6B to $16.9B in 2020.

Avalere analysis finds that Medicare fee-for-service (FFS) patients with an RA diagnosis and conditions associated with undermanaged disease have 121% higher medical costs than other RA patients. Part D costs were 30% higher for those with undermanaged disease than for other RA patients.

Avalere analysis finds that in the top 25 US counties with highest number of COVID-19 diagnoses, two-thirds of Medicare beneficiaries have 1 or more high-risk medical conditions.

Opportunities exist to accelerate potential vaccine development.

On November 13, Avalere policy experts published a piece in the Health Affairs blog about considerations for developing and harmonizing HIV prevention recommendations to drive the goal of eliminating HIV.